Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003466743 | SCV004216718 | likely pathogenic | Bardet-Biedl syndrome 14 | 2023-01-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004723330 | SCV005340050 | likely pathogenic | CEP290-related disorder | 2024-06-22 | no assertion criteria provided | clinical testing | The CEP290 c.1516delC variant is predicted to result in a frameshift and premature protein termination (p.Arg506Valfs*9). To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. Frameshift variants in CEP290 are expected to be pathogenic. This variant is interpreted as likely pathogenic. |